Our professionals

La imagen muestra al Dr. Felipe Prósper Cardoso, especialista en terapia celular de la Clínica Universidad de Navarra.

Dr. Felipe Prósper

Co-Director of the Hemato-Oncology Program.
Principal Investigator of the Translational Hematology group.
Director of the Cell Therapy Area.
Co-Director of the Hematology and Hemotherapy Service.
Specialist in Hematology and Oncology.

Be part of: Cima Universidad de Navarra Clínica Universidad de Navarra Cancer Center Clínica Universidad de Navarra
INDEX H 63

Professional career

MD (1988) and PhD in Medicine (1994), University of Navarra. Specialist in Hematology and Hemotherapy, Clínica Universidad de Navarra. He completed his training with a fellowship in Hematology and Oncology at the University of Minnesota (1997).

Director of the Cell Therapy Area and Co-Director of the Hematology Service at Clínica Universidad de Navarra.

Deputy Director of the Navarra Health Research Institute (IdiSNA) since February 2022.

RESEARCH AREAS

Member of the editorial board of 15 national and international scientific journals.

Evaluator for the National Agency for Evaluation and Forecasting (ANEP) from 1999 to the present.

Evaluator for the Government of Andalusia from 2006 to the present.

Expert Evaluator of Research Projects in the European Union since 2007 to the present.

Coordinator of the Oncology and Hematology Area and member of the Internal Scientific Committee of the Navarra Health Research Institute. Appointed by the Government of Navarre (Department of Health) on February 11, 2014.

President of the Research Committee at Clínica Universidad de Navarra (since January 2014–present).

Has led more than 30 clinical trials as principal investigator.

Has directed more than 50 research projects, obtaining funding from institutions such as FIS, the Ministry of Science and Technology, European projects, and private institutions. 

Positive research evaluation (six-year terms/sexenios). Advisory Committee of the National Commission for the Evaluation of Research Activity. Evaluation request for the period 1996-2013. Date: June 18, 2014.

AREAS OF INTEREST

Evaluation and treatment of:

  • Myelomas
  • Chronic myeloproliferative syndromes
  • Leukemias

He leads a research and clinical application program in cell therapy with adult stem cells, advancing several research lines focused primarily on the use of stem cells to treat cardiovascular, osteoarticular, and immune-mediated diseases. He also maintains and develops a research line on epigenetic control mechanisms in both hematologic neoplasms and healthy stem cells, aimed at investigating the role of these mechanisms in regulating self-renewal and differentiation. 

Activity

In teaching

Accredited as Assistant Professor (PhD) and Private University Professor at the University of Navarra by ANECA (2007), and as Tenured University Professor (Medicine) in 2009.

Has supervised 21 doctoral theses, all receiving the highest distinction, including 2 extraordinary awards.

In research

Has delivered more than 260 invited lectures and has organized and moderated sessions at national and international conferences.

Has published more than 220 articles in national and international journals.

Has published 24 national and international book chapters.

Imagen de un icono azul con un documento certificado.

Acknowledgments

  • Spanish Association of Hematology and Hemotherapy (AEHH) since 1990.
  • American Society of Hematology (ASH) since 1994.
  • International Society of Experimental Hematology (ISEH) since 1995.
  • Spanish Association for Cancer Research (ASEICA) since 2002.
  • European Hematology Association (EHA) since 2009.

Scientific organizations

  • Young Investigator Award. Blood Club. Central Society of Clinical Investigation. Chicago 1996.
  • Award for Best Applied Basic or Clinical Research Project in Breast Cancer. Novartis: Effects of inhibition of the tyrosine kinase activity of epidermal growth factor (EGF) family receptors on the regulation of breast cancer cell proliferation and apoptosis (2001).
  • Rafael Hervada Biomedical Research Award: Myocardial regeneration with autologous myoblasts: experimental and clinical study. Rafael Hervada Hospital. December 2005.
  • Second Prize Bayer-Schering-Pharma 2007 Award in Research in Lymphoproliferative Syndromes: Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. XLIX National Meeting of AEHH and XXIII National SETH Congress. Pamplona, October 2007.
  • FEHH-ASTRA ZENECA 2007 Award. Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia. XLIX National Meeting of AEHH and XXIII National SETH Congress. Pamplona, October 2007.
  • BIAL Award 2009. The role of Epigenetics in the Prognosis and Pathogenesis of Acute Lymphoblastic Leukemia. Lisbon. Lisbon. May 2009.

Latest scientific publications

More information